Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2014
09/18/2014WO2014142705A1 A cytokine-containing drug having an antiviral, antimicrobial, immunomodulatory and anti-inflammatory effect for treating and prophylaxis of infectious diseases
09/18/2014WO2014142356A1 Therapeutic agent for scleroderma
09/18/2014WO2014142102A1 Liquid aqueous composition
09/18/2014WO2014141877A1 Tissue repair material
09/18/2014WO2014141683A1 Kntc2 peptides and vaccines containing the same
09/18/2014WO2014141652A1 Smyd3 peptides and vaccines containing the same
09/18/2014WO2014141244A1 Synthetic peptides for the treatment of autoimmune diseases
09/18/2014WO2014141165A1 Use of insulin signaling antagonists, optionally in combination of transfection of non-beta cells, for inducing insulin production
09/18/2014WO2014141149A1 Formulations with reduced viscosity
09/18/2014WO2014141124A1 Erk-pathway activating compound for preventing or treating leptin resistance
09/18/2014WO2014141121A1 Composition containing digestive enzymes and nutrients suitable for enteral administration
09/18/2014WO2014140504A1 Bone substitutes grafted by mimetic peptides of human bmp-2 protein
09/18/2014WO2014140391A1 Use of garvicin a as an antimicrobial product
09/18/2014WO2014140284A1 Use of linagliptin in cardio- and renoprotective antidiabetic therapy
09/18/2014WO2014139894A1 Homoarginine as therapeutic for the reduction of myocardial remodeling
09/18/2014WO2014139809A1 Method and kit for producing biomaterial for tissue regeneration
09/18/2014WO2014139472A1 Compositions and methods of using islet neogenesis peptides and analogs thereof
09/18/2014WO2014139468A1 Fusion protein molecules and method of use
09/18/2014WO2014139329A1 Spray-dried powder comprising vancomycin hydrochloride, and industrial manufacturing method thereof
09/18/2014WO2014139227A1 Lump sugar, and production method and application thereof
09/18/2014WO2014139182A1 Compositions and methods of using islet neogenesis peptides and analogs thereof
09/18/2014WO2014139168A1 Preparation process of polymeric microspheres
09/18/2014WO2014139014A1 Methods and compositions for the inhibition of vascular endothelial growth factor activity and vascular permeability
09/18/2014WO2014139008A1 Small molecule modulators of pcsk9 and methods of use thereof
09/18/2014WO2014138953A1 Treatment of endometriosis, angiogenesis and/or endometrial lesion growth
09/18/2014WO2014138927A1 Treatment of gluten intolerance and related conditions
09/18/2014WO2014138921A1 Enhanced liquid formulation stability of erythropoietin alpha through purification processing
09/18/2014WO2014138819A1 Agents that neutralize il-3 signaling and uses thereof
09/18/2014WO2014138796A1 Dosage regimen for therapeutic method
09/18/2014US20140276493 Wound healing compositions
09/18/2014US20140275904 Sensors, Sensor Systems and Methods
09/18/2014US20140275479 Specific binding agents of human angiopoeitin-2
09/18/2014US20140275230 Methods and compositions for increasing sialic acid production and treating sialic related disease conditions
09/18/2014US20140275226 Method of controlling coagulation
09/18/2014US20140275225 Modulators of pharmacological agents
09/18/2014US20140275212 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
09/18/2014US20140274915 Methods of Use for Recombinant Human Secretoglobins
09/18/2014US20140274905 Methods and compounds for calcium ion channel regulation
09/18/2014US20140274902 Recombinant fviii formulations
09/18/2014US20140274900 Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness
09/18/2014US20140274899 Preparations Containing Hepatocyte Growth Factor and Hyaluronic Acid and Methods of Making and Using Same
09/18/2014US20140274898 Hair growth methods using fgfr3 extracellular domains
09/18/2014US20140274897 Method for preventing and treating diabetes using neurturin
09/18/2014US20140274895 Methods And Non-Immunogenic Compositions For Treating Inflammatory Disorders
09/18/2014US20140274894 Methods for making cytokine compositions from tissues using non-centrifugal methods
09/18/2014US20140274893 Methods and Acellular Compositions For Treating Inflammatory Disorders
09/18/2014US20140274892 Reducing the risk of autoimmune disease
09/18/2014US20140274891 Method of generating an index score for mbl deficiency to predict cardiodiabetes risk
09/18/2014US20140274886 Methods and systems for adjusting rumen undegraded protein in animal diets
09/18/2014US20140274883 Novel antiviral compounds from marine extracts
09/18/2014US20140274881 Biodegradable therapeutic nanoparticles containing an antimicrobial agent
09/18/2014US20140274879 Methods of use for an antimicrobial peptide
09/18/2014US20140274873 Composition of a sustained-release delivery and method of stabilizing proteins during fabrication process
09/18/2014US20140273204 Method Of Producing A Paralytic Peptide
09/18/2014US20140271938 Systems and methods for delivery of peptides
09/18/2014US20140271937 Brain and neural treatments comprising peptides and other compositions
09/18/2014US20140271936 Memory or learning using peptide and other compositions
09/18/2014US20140271935 Methods and systems for treating or preventing cancer
09/18/2014US20140271934 Peptide systems and methods for metabolic conditions
09/18/2014US20140271926 Methods of use of glutamine synthetase inhibitors
09/18/2014US20140271923 Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
09/18/2014US20140271914 Bone graft materials containing calcium phosphate and chitosan
09/18/2014US20140271902 Particulate hyaluronic acid formulations for cellular delivery of bioactive agents
09/18/2014US20140271901 Management of Tractional Membranes
09/18/2014US20140271897 Compositions, methods and devices for local drug delivery
09/18/2014US20140271888 Diketopiperazine microparticles with defined specific surface areas
09/18/2014US20140271886 Bioerodible Silicon-Based Compositions for Delivery of Therapeutic Agents
09/18/2014US20140271870 Treatment of pain using protein solutions
09/18/2014US20140271868 Treatment of achondroplasia with encapsulated cnp-secreting cells
09/18/2014US20140271861 Matrix compositions for controlled release of peptide and polypeptide molecules
09/18/2014US20140271855 Sovaprevir tablets
09/18/2014US20140271824 Acid Stable Liposomal Compositions And Methods For Producing The Same
09/18/2014US20140271811 Topical systems and methods for treating sexual dysfunction
09/18/2014US20140271808 Systems and methods for delivery of peptides
09/18/2014US20140271807 Brain and neural treatments comprising peptides and other compositions
09/18/2014US20140271806 Memory or learning using peptide and other compositions
09/18/2014US20140271805 Compositions and methods for affecting mood states
09/18/2014US20140271804 Methods and systems for treating or preventing cancer
09/18/2014US20140271803 Peptide systems and methods for metabolic conditions
09/18/2014US20140271802 Wound healing using topical systems and methods
09/18/2014US20140271801 Cardiovascular disease treatment and prevention
09/18/2014US20140271764 Bioerodible Silicon-Based Delivery Vehicles for Delivery of Therapeutic Agents
09/18/2014US20140271735 Use of calcitonin in osteoarthritis
09/18/2014US20140271732 Wound healing using topical systems and methods
09/18/2014US20140271731 Cardiovascular disease treatment and prevention
09/18/2014US20140271730 Immune modulation using peptides and other compositions
09/18/2014US20140271724 Methods and compositions for treating or preventing cancer
09/18/2014US20140271695 Immunogenic lhrh compositions and methods relating thereto
09/18/2014US20140271684 Pd-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof
09/18/2014US20140271668 Increasing parkin activity by administering a deubiquitinating enzyme inhibitor
09/18/2014US20140271660 Monoclonal antibodies against antithrombin beta
09/18/2014US20140271645 Method for treating inflammation
09/18/2014US20140271637 Methods of administering anti-tnfalpha antibodies
09/18/2014US20140271625 Methods for treating bleeding disorders
09/18/2014US20140271613 Surgical Compositions
09/18/2014US20140271612 Treatment Method and Product for Uterine Fibroids using Purified Collagenase
09/18/2014US20140271609 In vivo temporal control of activatable matrix-degrading enzymes
09/18/2014US20140271608 Resorption enhancers as additives to improve the oral formulation of low molecular weight heparins
09/18/2014US20140271607 Blood coagulation factor vii and viia derivatives, conjugates and complexes comprising the same, and use thereof
09/18/2014US20140271606 Methods of using adenosine receptor antagonists for treating bleeding disorders
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 3163